Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05596409
Title ELACESTRANT in Women and Men With CDK4/6 Inhibitor-Naive Estrogen Receptor Positive, HER-2 Negative Metastatic Breast Cancer Study (ELCIN)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Stemline Therapeutics, Inc.
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.